AdaptHealth Corp. (NASDAQ:AHCO) Receives $14.14 Average Price Target from Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have earned a consensus recommendation of “Moderate Buy” from the nine analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $14.1429.

Several research analysts have commented on AHCO shares. Robert W. Baird lowered their price target on shares of AdaptHealth from $18.00 to $15.00 and set an “outperform” rating for the company in a report on Monday, July 6th. Canaccord Genuity Group raised their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. UBS Group reduced their price objective on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Jefferies Financial Group raised shares of AdaptHealth from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $11.00 to $13.00 in a research report on Tuesday, July 21st. Finally, Truist Financial boosted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Monday, April 13th.

Insiders Place Their Bets

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the completion of the sale, the insider directly owned 136,538 shares of the company’s stock, valued at $1,373,572.28. The trade was a 7.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in AdaptHealth by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock worth $656,000 after purchasing an additional 2,564 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in AdaptHealth by 32.4% in the first quarter. Goldman Sachs Group Inc. now owns 571,232 shares of the company’s stock valued at $6,192,000 after purchasing an additional 139,828 shares in the last quarter. Woodline Partners LP acquired a new position in AdaptHealth in the first quarter valued at approximately $2,851,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in AdaptHealth by 18.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock valued at $2,534,000 after purchasing an additional 35,879 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in AdaptHealth by 1.3% in the second quarter. JPMorgan Chase & Co. now owns 211,769 shares of the company’s stock valued at $1,997,000 after purchasing an additional 2,718 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Down 3.8%

Shares of NASDAQ:AHCO opened at $10.79 on Friday. The firm’s 50 day moving average price is $10.27 and its 200 day moving average price is $10.67. The stock has a market cap of $1.47 billion, a price-to-earnings ratio of -17.40, a price-to-earnings-growth ratio of 0.57 and a beta of 1.45. AdaptHealth has a fifty-two week low of $8.51 and a fifty-two week high of $13.43. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 1.21.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.